![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
-- The national disease awareness campaign aims to educate and drive conversation about recognizing and managing non-motor symptoms of Parkinson’s, including hallucinations and delusions...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, 2024 at...
- Second quarter total net product sales of $242.0 million, up 46% year-over-year Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended...
Company to host conference call and webcast on Tuesday, August 6, 2024, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter...
-- Continued Improvements in RSBQ and CGI-I scores seen with long-term DAYBUE treatment in Phase 3 LAVENDER™ and LILAC studies -- DAYBUE safety profile was consistent with findings from the...
Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be presented at the 2024 International Rett Syndrome Foundation...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -4.6511627907 | 1.075 | 1.075 | 1.025 | 112631 | 1.04615598 | DE |
4 | -0.025 | -2.38095238095 | 1.05 | 1.125 | 1.025 | 267466 | 1.08510019 | DE |
12 | -1.275 | -55.4347826087 | 2.3 | 2.3 | 1.025 | 770018 | 1.26110994 | DE |
26 | 0.175 | 20.5882352941 | 0.85 | 3.2 | 0.85 | 746089 | 1.52052755 | DE |
52 | -1.325 | -56.3829787234 | 2.35 | 3.2 | 0.7 | 634524 | 1.42466219 | DE |
156 | -1.875 | -64.6551724138 | 2.9 | 18.25 | 0.7 | 752117 | 6.97758552 | DE |
260 | -3.725 | -78.4210526316 | 4.75 | 18.25 | 0.7 | 738818 | 5.50146147 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions